Point-of-care testing: Where is the evidence? A systematic survey

Clinical Chemistry and Laboratory Medicine

Volumn 52, Issue 3, 2014, Pages 313-324

  Pecoraro, Valentina ^a   Germagnoli, Luca ^b   Banfi, Giuseppe ^c  

^a IRCCS ISTITUTO ORTOPEDICO GALEAZZI   (Italy)

^b Unilabs   (France)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Clinical decision making; Clinical outcome; Diagnostic applications; Evidence; Patient management; Point of care testing; Quality of reporting

Indexed keywords

BILIRUBIN; PARATHYROID HORMONE; PROCALCITONIN; TROPONIN;

ANALYTIC METHOD; BLOOD GAS ANALYSIS; CLINICAL DECISION MAKING; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; COMPARATIVE STUDY; EMBASE; EVIDENCE BASED PRACTICE; HUMAN; LABORATORY DEVICE; MEDLINE; OUTCOME ASSESSMENT; PATIENT CARE; POINT OF CARE TESTING; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; SYSTEMATIC REVIEW; SYSTEMATIC REVIEW (TOPIC);

DATA COLLECTION; EVIDENCE-BASED MEDICINE; HUMANS; POINT-OF-CARE SYSTEMS; TREATMENT OUTCOME;

EID: 84896116209     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2013-0386     Document Type: Review

References (100)

1. Kendall J, Reeves B, Clancy M. Point of care testing: randomised controlled trial of clinical outcome. Br Med J 1998;316: 1052-7.
2. Fleisher M. Point-of-care testing: does it really improve patient care. Clin Biochem 1993;26:6-8.
3. Price CP, St John A, Kricka LJ. Putting point-of-care testing into context: moving beyond innovation to adoption. In: Price CP, St John A, Kricka LR, editors. Point-of-care testing, 3rd ed. Washington DC: AACC Press, 2010:1-20.
4. St John A. The evidence to support point-of-care testing. Clin Biochem Rev 2010;31:111-9.
5. Price CP. Point of care testing. Br Med J 2001;322:1285-8.
6. Briedigkeit L, Muller-Plathe O, Schlebusch H, Ziems J. Recommendations of the German working group on medical laboratory testing (AML) on the introduction and quality assurance of procedures for point-of-care testing (POCT) in hospitals. Clin Chem Lab Med 1999;37:919-25.
7. Nichols JH, Christenson RH, Clarke W, Gronowski A, Hammett-Stabler CA, Jacobs E, et al. Executive summary. The national academy of clinical biochemistry laboratory medicine practice guideline: evidence-based practice for point-of-care testing. Clin Chim Acta 2007;379:14-28.
8. Higgins JP, Green S, editors. Cochrane handbook for systematic reviews of interventions. John Wiley & Sons Ltd, 2011.
9. Reeves BC, Deeks JJ, Higgins JP, Wells GA. Including non-randomized studies. In: Higgins JP, Green S, editors. Cochrane handbook for systematic reviews of interventions. Chichester, West Sussex: John Wiley & Sons Ltd, 2011.
10. Crowther MA. Introduction to surrogates and evidence-based mini-reviews. Hematology Am Soc Hematol Educ Program 2009:15-6.
11. Higgins JP, Altman DG. Assessing risk of bias in included studies. In: Higgins JP, Green S, editors. Cochrane handbook for systematic reviews of interventions. Chichester, West Sussex: John Wiley & Sons Ltd, 2008.
12. Barko HA, Jackson GL, Engle WD. Evaluation of a point-of-care direct spectrophotometric method for measurement of total serum bilirubin in term and near-term neonates. J Perinatol 2006;26:100-5.
13. Bhutani VK, Gourley GR, Adler S, Kreamer B, Dalin C, Johnson LH. Noninvasive measurement of total serum bilirubin in a multiracial predischarge newborn population to assess the risk of severe hyperbilirubinemia. Pediatrics 2000; 106:E17.
14. Borgard JP, Szymanowicz A, Pellae I, Szmidt-Adjide V, Rota M. Determination of total bilirubin in whole blood from neonates: results from a French multicenter study. Clin Chem Lab Med 2006;44:1103-10.
15. Engle WD, Jackson GL, Sendelbach D, Manning D, Frawley WH. Assessment of a transcutaneous device in the evaluation of neonatal hyperbilirubinemia in a primarily Hispanic population. Pediatrics 2002;110:61-7.
16. Ho HT, Ng TK, Tsui KC, Lo YC. Evaluation of a new transcutaneous bilirubinometer in Chinese newborns. Arch Dis Child Fetal Neonatal Ed 2006;91:F434-8.
17. Kazmierczak SC, Robertson AF, Briley KP, Kreamer B, Gourley GR. Transcutaneous measurement of bilirubin in newborns: comparison with an automated Jendrassik-Grof procedure and HPLC. Clin Chem 2004;50:433-5.
18. Lam TS, Tsui KL, Kam CW. Evaluation of a point-of-care transcutaneous bilirubinometer in Chinese neonates at an accident and emergency department. Hong Kong Med J 2008;14:356-60.
19. Maisels MJ, Ostrea EM, Jr., Touch S, Clune SE, Cepeda E, Kring E, et al. Evaluation of a new transcutaneous bilirubinometer. Pediatrics 2004;113:1628-35.
20. Mielsch C, Zimmermann A, Wagner D, Matthes B, Schlebusch H, Luppa PB. Point-of-care determination of neonatal bilirubin with the blood gas analyzer RapidLab 1265. Clin Chem Lab Med 2010;48:1455-61.
21. Robertson A, Kazmierczak S, Vos P. Improved transcutaneous bilirubinometry: comparison of SpectR(X) BiliCheck and Minolta jaundice meter JM-102 for estimating total serum bilirubin in a normal newborn population. J Perinatol 2002;22:12-4.
22. Rolinski B, Kuster H, Ugele B, Gruber R, Horn K. Total bilirubin measurement by photometry on a blood gas analyzer: potential for use in neonatal testing at the point of care. Clin Chem 2001;47:1845-7.
23. Rubaltelli FF, Gourley GR, Loskamp N, Modi N, Roth-Kleiner M, Sender A, et al. Transcutaneous bilirubin measurement: a multicenter evaluation of a new device. Pediatrics 2001;107:1264-71.
24. Schmidt ET, Wheeler CA, Jackson GL, Engle WD. Evaluation of transcutaneous bilirubinometry in preterm neonates. J Perinatol 2009;29:564-9.
25. Schumacher RE, Thornbery JM, Gutcher GR. Transcutaneous bilirubinometry: a comparison of old and new methods. Pediatrics 1985;76:10-4.
26. Tan KL, Chia HP, Koh BC. Transcutaneous bilirubinometry in Chinese, Malay and Indian infants. Acta Paediatr 1996;85: 986-90.
27. Tayaba R, Gribetz D, Gribetz I, Holzman IR. Noninvasive estimation of serum bilirubin. Pediatrics 1998;102:E28.
28. Wong CM, van Dijk PJ, Laing IA. A comparison of transcutaneous bilirubinometers: SpectRx BiliCheck versus Minolta AirShields. Arch Dis Child Fetal Neonatal Ed 2002;87:F137-40.
29. Yamanouchi I, Yamauchi Y, Igarashi I. Transcutaneous bilirubinometry: preliminary studies of noninvasive transcutaneous bilirubin meter in the Okayama National Hospital. Pediatrics 1980;65:195-202.
30. Yamauchi Y, Yamanouchi I. Transcutaneous bilirubinometry. Evaluation of accuracy and reliability in a large population. Acta Paediatr Scand 1988;77:791-5.
31. Bektas F, Soyuncu S, Gunduz I, Basarici I, Akbas H, Eken C. The value of procalcitonin, a novel inflammatory marker, in the diagnosis of myocardial infarction and evaluation of acute coronary syndrome patients. J Emerg Med 2011;41:524-30.
32. Galetto-Lacour A, Zamora SA, Gervaix A. Bedside procalcitonin and C-reactive protein tests in children with fever without localizing signs of infection seen in a referral center. Pediatrics 2003;112:1054-60.
33. Hesselink DA, Burgerhart JS, Bosmans-Timmerarends H, Petit P, van Genderen PJ. Procalcitonin as a biomarker for severe Plasmodium falciparum disease: a critical appraisal of a semi-quantitative point-of-care test in a cohort of travellers with imported malaria. Malar J 2009;8:206.
34. Meisner M, Brunkhorst FM, Reith HB, Schmidt J, Lestin HG, Reinhart K. Clinical experiences with a new semi-quantitative solid phase immunoassay for rapid measurement of procalcitonin. Clin Chem Lab Med 2000;38:989-95.
35. Agarwal G, Barakate MS, Robinson B, Wilkinson M, Barraclough B, Reeve TS, et al. Intraoperative quick parathyroid hormone versus same-day parathyroid hormone testing for minimally invasive parathyroidectomy: a cost-effectiveness study. Surgery 2001;130:963-70.
36. Chou FF, Lee CH, Chen JB, Hsu KT, Sheen-Chen SM. Intraoperative parathyroid hormone measurement in patients with secondary hyperparathyroidism. Arch Surg 2002;137:341-4.
37. Garner SC, Leight GS, Jr. Initial experience with intraoperative PTH determinations in the surgical management of 130 consecutive cases of primary hyperparathyroidism. Surgery 1999;126:1132-7.
38. Johnson LR, Doherty G, Lairmore T, Moley JF, Brunt LM, Koenig J, et al. Evaluation of the performance and clinical impact of a rapid intraoperative parathyroid hormone assay in conjunction with preoperative imaging and concise parathyroidectomy. Clin Chem 2001;47:919-25.
39. Mace AD, Randhawa PS, Woolman E, Stearns MP. Intra-operative parathyroid hormone monitoring using a laboratory based multichannel analyser. Clin Otolaryngol 2008;33:134-7.
40. Sokoll LJ, Drew H, Udelsman R. Intraoperative parathyroid hormone analysis: a study of 200 consecutive cases. Clin Chem 2000;46:1662-8.
41. Apple FS, Anderson FP, Collinson P, Jesse RL, Kontos MC, Levitt MA, et al. Clinical evaluation of the first medical whole blood, point-of-care testing device for detection of myocardial infarction. Clin Chem 2000;46:1604-9.
42. Apple FS, Chung AY, Kogut ME, Bubany S, Murakami MM. Decreased patient charges following implementation of pointof-care cardiac troponin monitoring in acute coronary syndrome patients in a community hospital cardiology unit. Clin Chim Acta 2006;370:191-5.
43. Birkhahn RH, Haines E, Wen W, Reddy L, Briggs WM, Datillo PA. Estimating the clinical impact of bringing a multimarker cardiac panel to the bedside in the ED. Am J Emerg Med 2010;29:304-8.
44. Bock JL, Singer AJ, Thode HC, Jr. Comparison of emergency department patient classification by point-of-care and central laboratory methods for cardiac troponin I. Am J Clin Pathol 2008;130:132-5.
45. Caragher TE, Fernandez BB, Jacobs FL, Barr LA. Evaluation of quantitative cardiac biomarker point-of-care testing in the emergency department. J Emerg Med 2002;22:1-7.
46. Collinson PO, John C, Lynch S, Rao A, Canepa-Anson R, Carson E, et al. A prospective randomized controlled trial of point-ofcare testing on the coronary care unit. Ann Clin Biochem 2004;41:397-404.
47. Cramer GE, Kievit PC, Brouwer MA, de Keijzer MH, Luijten HE, Verheugt FW. Lack of concordance between a rapid bedside and conventional laboratory method of cardiac troponin testing: impact on risk stratification of patients suspected of acute coronary syndrome. Clin Chim Acta 2007;381:164-6.
48. Di Serio F, Amodio G, Varraso L, Campaniello M, Coluccia P, Trerotoli P, et al. Integration between point-of-care cardiac markers in an emergency/cardiology department and the central laboratory: methodological and preliminary clinical evaluation. Clin Chem Lab Med 2005;43:202-9.
49. Esposito EC, Hollander JE, Ryan RJ, Schreiber D, O'Neil B, Jackson R, et al. Predictors of 30-day cardiovascular events in patients with prior percutaneous coronary intervention or coronary artery bypass grafting. Acad Emerg Med 2011;18:613-8.
50. Goodacre SW, Bradburn M, Cross E, Collinson P, Gray A, Hall AS. The randomised assessment of treatment using panel assay of cardiac markers (RATPAC) trial: a randomised controlled trial of point-of-care cardiac markers in the emergency department. Heart 2011;97:190-6.
51. Group RS. Evaluation of a bedside whole-blood rapid troponin T assay in the emergency department. Rapid evaluation by assay of cardiac troponin T (REACTT) investigators study group. Acad Emerg Med 1997;4:1018-24.
52. Hallani H, Leung DY, Newland E, Juergens CP. Use of a quantitative point-of-care test for the detection of serum cardiac troponin T in patients with suspected acute coronary syndromes. Intern Med J 2005;35:560-2.
53. Heeschen C, Goldmann BU, Moeller RH, Hamm CW. Analytical performance and clinical application of a new rapid bedside assay for the detection of serum cardiac troponin I. Clin Chem 1998;44:1925-30.
54. Hindle HR, Hindle SK. Qualitative troponin I estimation in the diagnosis of acute coronary syndromes in three rural hospitals. Can J Rural Med 2005;10:225-30.
55. Hjortshoj S, Venge P, Ravkilde J. Clinical performance of a new point-of-care cardiac troponin I assay compared to three laboratory troponin assays. Clin Chim Acta 2011;412:370-5.
56. Lee-Lewandrowski E, Corboy D, Lewandrowski K, Sinclair J, McDermot S, Benzer TI. Implementation of a point-of-care satellite laboratory in the emergency department of an academic medical center. Impact on test turnaround time and patient emergency department length of stay. Arch Pathol Lab Med 2003;127:456-60.
57. Loten C, Attia J, Hullick C, Marley J, McElduff P. Point of care troponin decreases time in the emergency department for patients with possible acute coronary syndrome: a randomised controlled trial. Emerg Med J 2010;27:194-8.
58. Macdonald SP, Nagree Y. Rapid risk stratification in suspected acute coronary syndrome using serial multiple cardiac biomarkers: a pilot study. Emerg Med Australas 2008;20:403-9.
59. McCord J, Nowak RM, McCullough PA, Foreback C, Borzak S, Tokarski G, et al. Ninety-minute exclusion of acute myocardial infarction by use of quantitative point-of-care testing of myoglobin and troponin I. Circulation 2001;104:1483-8.
60. Muller-Bardorff M, Sylven C, Rasmanis G, Jorgensen B, Collinson PO, Waldenhofer U, et al. Evaluation of a point-ofcare system for quantitative determination of troponin T and myoglobin. Clin Chem Lab Med 2000;38:567-74.
61. Ordonez-Llanos J, Santalo-Bel M, Merce-Muntanola J, Collinson PO, Gaze D, Haass M, et al. Risk stratification of chest pain patients by point-of-care cardiac troponin T and myoglobin measured in the emergency department. Clin Chim Acta 2006;365:93-7.
62. Ryan RJ, Lindsell CJ, Hollander JE, O'Neil B, Jackson R, Schreiber D, et al. A multicenter randomized controlled trial comparing central laboratory and point-of-care cardiac marker testing strategies: the disposition impacted by serial point of care markers in acute coronary syndromes (DISPO-ACS) trial. Ann Emerg Med 2009;53:321-8.
63. Singer AJ, Viccellio P, Thode HC, Jr., Bock JL, Henry MC. Introduction of a stat laboratory reduces emergency department length of stay. Acad Emerg Med 2008;15:324-8.
64. van Domburg RT, Cobbaert C, Kimman GJ, Zerback R, Simoons ML. Long-term prognostic value of serial troponin T bedside tests in patients with acute coronary syndromes. Am J Cardiol 2000;86:623-7.
65. Venge P, Ohberg C, Flodin M, Lindahl B. Early and late outcome prediction of death in the emergency room setting by pointof-care and laboratory assays of cardiac troponin I. Am Heart J 2010;160:835-41.
66. Arora S, Henderson SO, Long T, Menchine M. Diagnostic accuracy of point-of-care testing for diabetic ketoacidosis at emergency-department triage: {beta}-hydroxybutyrate versus the urine dipstick. Diabetes Care 2011;34:852-4.
67. Bailey PL, McJames SW, Cluff ML, Wells DT, Orr JA, Westenskow DR, et al. Evaluation in volunteers of the VIA V-ABG automated bedside blood gas, chemistry, and hematocrit monitor. J Clin Monit Comput 1998;14:339-46.
68. Beneteau-Burnat B, Bocque MC, Lorin A, Martin C, Vaubourdolle M. Evaluation of the blood gas analyzer Gem PREMIER 3000. Clin Chem Lab Med 2004;42:96-101.
69. Beneteau-Burnat B, Pernet P, Pilon A, Latour D, Goujon S, Feuillu A, et al. Evaluation of the GEM premier 4000: a compact blood gas CO-Oximeter and electrolyte analyzer for point-of-care and laboratory testing. Clin Chem Lab Med 2008;46:271-9.
70. Chance JJ, Li DJ, Sokoll LJ, Silberman MA, Engelstad ME, Nichols JH, et al. Multiple site analytical evaluation of a portable blood gas/electrolyte analyzer for point of care testing. Crit Care Med 2000;28:2081-5.
71. Coplin WM, O'Keefe GE, Grady MS, Grant GA, March KS, Winn HR, et al. Accuracy of continuous jugular bulb oximetry in the intensive care unit. Neurosurgery 1998;42:533-9.
72. Dohgomori H, Arikawa K, Kanmura Y. Accuracy of a point-of-care blood gas analyzer in gastric tonometry measurements of intramucosal pH (pHi) and P(CO2) gap. J Anesth 2004; 18:14-7.
73. Frasca D, Dahyot-Fizelier C, Catherine K, Levrat Q, Debaene B, Mimoz O. Accuracy of a continuous noninvasive hemoglobin monitor in intensive care unit patients. Crit Care Med 2011;39:2277-82.
74. Gayat E, Bodin A, Sportiello C, Boisson M, Dreyfus JF, Mathieu E, et al. Performance evaluation of a noninvasive hemoglobin monitoring device. Ann Emerg Med 2011;57:330-3.
75. Gehring H, Hornberger C, Dibbelt L, Rothsigkeit A, Gerlach K, Schumacher J, et al. Accuracy of point-of-care-testing (POCT) for determining hemoglobin concentrations. Acta Anaesthesiol Scand 2002;46:980-6.
76. Grosse FO, Holzhey D, Falk V, Schaarschmidt J, Kraemer K, Mohr FW. In vitro comparison of the new in-line monitor BMU 40 versus a conventional laboratory analyzer. J Extra Corpor Technol 2010;42:61-70.
77. Halpern MT, Palmer CS, Simpson KN, Chesley FD, Luce BR, Suyderhoud JP, et al. The economic and clinical efficiency of point-of-care testing for critically ill patients: a decisionanalysis model. Am J Med Qual 1998;13:3-12.
78. Hinkelbein J, Floss F, Denz C, Krieter H. Accuracy and precision of three different methods to determine Pco2 (Paco2 vs. Petco2 vs. Ptcco2) during interhospital ground transport of critically ill and ventilated adults. J Trauma 2008;65:10-8.
79. Jacobs E, Nowakowski M, Colman N. Performance of Gem premier blood gas/electrolyte analyzer evaluated. Clin Chem 1993;39:1890-3.
80. Jain A, Subhan I, Joshi M. Comparison of the point-of-care blood gas analyzer versus the laboratory auto-analyzer for the measurement of electrolytes. Int J Emerg Med 2009;2:117-20.
81. Kilgore ML, Steindel SJ, Smith JA. Evaluating stat testing options in an academic health center: therapeutic turnaround time and staff satisfaction. Clin Chem 1998;44:1597-603.
82. Kulkarni A, Saxena M, Price G, O'Leary MJ, Jacques T, Myburgh JA. Analysis of blood glucose measurements using capillary and arterial blood samples in intensive care patients. Intensive Care Med 2005;31:142-5.
83. Leino A, Kurvinen K. Interchangeability of blood gas, electrolyte and metabolite results measured with point-of-care, blood gas and core laboratory analyzers. Clin Chem Lab Med 2011;49:1187-91.
84. Lindemans J, Hoefkens P, van Kessel AL, Bonnay M, Kulpmann WR, van Suijlen JD. Portable blood gas and electrolyte analyzer evaluated in a multiinstitutional study. Clin Chem 1999;45:111-7.
85. Ng IO, Liu CL, Fan ST, Ng M. Expression of P-glycoprotein in hepatocellular carcinoma. A determinant of chemotherapy response. Am J Clin Pathol 2000;113:355-63.
86. Papadea C, Foster J, Grant S, Ballard SA, Cate JC, Southgate WM, et al. Evaluation of the i-STAT portable clinical analyzer for pointof-care blood testing in the intensive care units of a university children's hospital. Ann Clin Lab Sci 2002;32:231-43.
87. Petersen JR, Graves DF, Tacker DH, Okorodudu AO, Mohammad AA, Cardenas VJ, Jr. Comparison of POCT and central laboratory blood glucose results using arterial, capillary, and venous samples from MICU patients on a tight glycemic protocol. Clin Chim Acta 2008;396:10-3.
88. Prause G, Ratzenhofer-Komenda B, Offner A, Lauda P, Voit H, Pojer H. Prehospital point of care testing of blood gases and electrolytes -an evaluation of IRMA. Crit Care 1997;1: 79-83.
89. Schlebusch H, Paffenholz I, Zerback R, Leinberger R. Analytical performance of a portable critical care blood gas analyzer. Clin Chim Acta 2001;307:107-12.
90. Sediame S, Zerah-Lancner F, d'Ortho MP, Adnot S, Harf A. Accuracy of the i-STAT bedside blood gas analyser. Eur Respir J 1999;14:214-7.
91. Steinfelder-Visscher J, Weerwind PW, Teerenstra S, Brouwer MH. Reliability of point-of-care hematocrit, blood gas, electrolyte, lactate and glucose measurement during cardiopulmonary bypass. Perfusion 2006;21:33-7.
92. Thomas FO, Hoffman TL, Handrahan DL, Crapo RO, Snow G. The measure of treatment agreement between portable and laboratory blood gas measurements in guiding protocol-driven ventilator management. J Trauma 2009;67:303-13.
93. Walton HG, Boucher DM, Marroquin R. Comparison of blood gas and electrolyte test results from the Gem-premier and the ABL-70 versus a conventional laboratory analyzer. J Extra Corpor Technol 2003;35:24-7.
94. Wax DB, Reich DL. Changes in utilization of intraoperative laboratory testing associated with the introduction of point-ofcare testing devices in an academic department. Anesth Analg 2007;105:1711-3.
95. Zaman Z, Demedts M. Blood gas analysis: POCT versus central laboratory on samples sent by a pneumatic tube system. Clin Chim Acta 2001;307:101-6.
96. Altinier S, Zaninotto M, Mion M, Carraro P, Rocco S, Tosato F, et al. Point-of-care testing of cardiac markers: results from an experience in an emergency department. Clin Chim Acta 2001;311:67-72.
97. Al-Ansary L, Farmer A, Hirst J, Roberts N, Glasziou P, Perera R, et al. Point-of-care testing for Hb A1c in the management of diabetes: a systematic review and metaanalysis. Clin Chem 2011;57:568-76.
98. Wu AH, Smith A, Christenson RH, Murakami MM, Apple FS. Evaluation of a point-of-care assay for cardiac markers for patients suspected of acute myocardial infarction. Clin Chim Acta 2004;346:211-9.
99. Gotzsche PC, Liberati A, Torri V, Rossetti L. Beware of surrogate outcome measures. Int J Technol Assess Health Care 1996;12:238-46.
100. la Cour JL, Brok J, Gotzsche PC. Inconsistent reporting of surrogate outcomes in randomised clinical trials: cohort study. Br Med J 2010;341:c3653.